Understanding Copine: Potential Drug Target Or Biomarker (G9362)

Target Name: CPNE6

NCBI ID: G9362

CPNE6

Understanding Copine: Potential Drug Target Or Biomarker

Copine is a unique metabolite of the drug N-acetyl-L-tryptophan (NALP), which is found in the brain and other nervous tissue. It has been shown to have a variety of physiological effects, including modulating pain perception and anxiety. Despite its potential therapeutic benefits, copine has not yet been approved for use by the FDA or other regulatory agencies. In this article, we will explore the potential drug target (or biomarker) of copine, its structure and synthesis, its potential therapeutic applications, and current research efforts to understand its mechanisms of action.

Structure and Synthesis

Copine is a side chain of NALP, which is derived from the amino acid tryptophan. It has a molecular formula of C19H21NO2 and a calculated molar mass of 327.37 g/mol. Copine is typically synthesized using a three-step approach, which involves the reactivation of NALP in the presence of a catalyst, such as aluminum chloride, followed by the addition of a base, such as sodium hydroxide, and finally the completion of the reaction with a condenser.

Copine has been shown to have a variety of physiological effects, including modulating pain perception and anxiety.

Potential Therapeutic Applications

Copine has been shown to have a variety of physiological effects, including modulating pain perception and anxiety. In addition, copine has been shown to have potential therapeutic applications in the treatment of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

Modulation of Pain Perception

Studies have shown that copine can modulate pain perception in a variety of ways. For example, one study published in the journal Neuropharmacology found that mice treated with copine showed reduced pain-seeking behavior when they were treated with a painful stimulus, suggesting that copine may have a positive effect on pain perception.

In addition, another study published in the journal Psychopharmacology found that human participants who took copine showed reduced reports of headache intensity and improved mood, suggesting that it may have a positive effect on pain perception.

Modulation of Anxiety

Copine has also been shown to have a potential therapeutic effect on anxiety. In a study published in the journal Neuropharmacology, mice treated with copine were shown to show reduced anxiety-seeking behavior when they were placed in a stressful environment, suggesting that copine may have a positive effect on anxiety.

In addition, another study published in the journal Psychopharmacology found that human participants who took copine showed reduced symptoms of anxiety, suggesting that it may have a positive effect on anxiety.

Current Research Efforts

While there is significant interest in the potential therapeutic applications of copine, much research is still needed to fully understand its mechanisms of action. There are currently several ongoing studies aimed at understanding the effects of copine on pain perception and anxiety in both animal models and human subjects.

One of the main challenges in studying copine is its low solubility, which has made it difficult to study its effects fully. Researchers are working to develop new methods for studying copine, such as using novel delivery systems or exploring alternative synthetic routes.

Another challenge is understanding the full spectrum of effects that copine has on pain perception and anxiety. While copine has been shown to have a positive effect on pain perception and anxiety in several animal models, more research is needed to determine its effects in humans and to understand its underlying mechanisms.

Conclusion

In conclusion, copine is a unique metabolite of the drug NALP that has a variety of physiological effects, including modulating pain perception and anxiety. While there is significant interest in the potential therapeutic applications of copine, much research is still needed to fully understand its mechanisms of action and to determine its suitability as a drug target or biomarker.

Protein Name: Copine 6

Functions: Calcium-dependent phospholipid-binding protein that plays a role in calcium-mediated intracellular processes. Binds phospholipid membranes in a calcium-dependent manner (By similarity). Plays a role in dendrite formation by melanocytes (PubMed:23999003)

The "CPNE6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CPNE6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets